e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Severity scores and comorbidities in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mortality in patients with COPD due to community acquired pneumonia
D. Snijders, M. van der Eerden, C. de Graaff, W. Boersma (Alkmaar, Netherlands)
Source:
Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Session:
Severity scores and comorbidities in community-acquired pneumonia
Session type:
Oral Presentation
Number:
418
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Snijders, M. van der Eerden, C. de Graaff, W. Boersma (Alkmaar, Netherlands). Mortality in patients with COPD due to community acquired pneumonia. Eur Respir J 2007; 30: Suppl. 51, 418
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Mortality in COPD patients with community-acquired pneumonia: who is the third partner?
Source: Eur Respir J 2006; 28: 262-263
Year: 2006
Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Cardiac diseases in patients with community acquired pneumonia (CAP)
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period
Source: Eur Respir J 2006; 28: Suppl. 50, 165s
Year: 2006
Mortality of patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 631s
Year: 2007
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Severity and outcome of community acquired pneumonia in asthmatic patients
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Significance of comorbidity in elderly patients with community acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 3s
Year: 2006
Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 106s
Year: 2006
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Outcome of community aquired pneumonia in elderly patients
Source: Eur Respir J 2006; 28: Suppl. 50, 530s
Year: 2006
In-hospital mortality risk assessment in patients with community acquired pneumonia
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Obesity and outcomes in patients hospitalized for pneumonia
Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections
Year: 2012
Comparison of H1N1 associated pneumonia with community acquired pneumonia in hospitalized patients
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
The incidence of Q fever in hospitalized patients with community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept